User profiles for Pedro Miranda

Pedro Cavaleiro Miranda

- Verified email at fc.ul.pt - Cited by 14264

Pedro MA Miranda

- Verified email at fc.ul.pt - Cited by 6575

Pedro Miranda

- Verified email at unex.es - Cited by 4104

[HTML][HTML] A technical guide to tDCS, and related non-invasive brain stimulation tools

…, D Liebetanz, C Miniussi, PC Miranda… - Clinical …, 2016 - Elsevier
Transcranial electrical stimulation (tES), including transcranial direct and alternating current
stimulation (tDCS, tACS) are non-invasive brain stimulation techniques increasingly used for …

Modeling the current distribution during transcranial direct current stimulation

PC Miranda, M Lomarev, M Hallett - Clinical neurophysiology, 2006 - Elsevier
OBJECTIVE: To investigate the spatial distribution of the magnitude and direction of the
current density in the human head during transcranial direct current stimulation (tDCS). …

EC-Earth: a seamless earth-system prediction approach in action

…, P Kållberg, T Koenigk, R McGrath, P Miranda… - Bulletin of the American …, 2010 - JSTOR
… JIMENEZ, COLIN JONES, PER KÅLLBERG, TORBEN KOENIGK, RAY MCGRATH,
PEDRO MIRANDA, TWAN VAN NOIJE, TIM PALMER, JOSÉ A. PARODI, TORBEN SCHMITH, …

Golimumab, a human antibody to tumour necrosis factor α given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the …

…, L Klareskog, EC Hsia, ST Hall, PC Miranda… - Annals of the …, 2009 - ard.bmj.com
Objective: The phase III GO-FORWARD study examined the efficacy and safety of golimumab
in patients with active rheumatoid arthritis (RA) despite methotrexate therapy. Methods: …

A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when …

DH Yoo, P Hrycaj, P Miranda, E Ramiterre… - Annals of the …, 2013 - ard.bmj.com
Objectives To compare the efficacy and safety of innovator infliximab (INX) and CT-P13, an
INX biosimilar, in active rheumatoid arthritis patients with inadequate response to …

A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in …

…, S Jeka, V Kovalenko, G Lysenko, P Miranda… - Annals of the …, 2013 - ard.bmj.com
Pedro Miranda6, … Dae Hyun Yoo Pawel Hrycaj Pedro Miranda Edgar Ramiterre Mariusz
Piotrowski Sergii Shevchuk Volodymyr Kovalenko Nenad Prodanovic Mauricio Abello-Banfi …

Transplantation of fecal microbiota from patients with irritable bowel syndrome alters gut function and behavior in recipient mice

…, Y Deng, J Jury, G Umeh, PM Miranda… - Science translational …, 2017 - science.org
Irritable bowel syndrome (IBS) is a common disorder characterized by altered gut function
and often is accompanied by comorbid anxiety. Although changes in the gut microbiota have …

Fundamentals of transcranial electric and magnetic stimulation dose: definition, selection, and reporting practices

AV Peterchev, TA Wagner, PC Miranda, MA Nitsche… - Brain stimulation, 2012 - Elsevier
BACKGROUND: The growing use of transcranial electric and magnetic (EM) brain stimulation
in basic research and in clinical applications necessitates a clear understanding of what …

Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a …

…, S Hall, E Ilivanova, F Irazoque-Palazuelos, P Miranda… - The Lancet, 2013 - thelancet.com
Background Clinical remission and low disease activity are essential treatment targets in
patients with rheumatoid arthritis. Although moderately active rheumatoid arthritis is common, …

Optimization of multifocal transcranial current stimulation for weighted cortical pattern targeting from realistic modeling of electric fields

G Ruffini, MD Fox, O Ripolles, PC Miranda… - Neuroimage, 2014 - Elsevier
Recently, multifocal transcranial current stimulation (tCS) devices using several relatively
small electrodes have been used to achieve more focal stimulation of specific cortical targets. …